Skip to main content
SpringerLink
Log in

Cultural Sensitivity and Informed Decision Making About Prostate Cancer Screening

  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Because informed consent for prostate cancer screening with prostate specific antigen (PSA) is recommended, we determined how African Americans, Hispanics, and Caucasians want information about screening with PSA and the digital rectal exam (DRE) presented in culturally sensitive brochures specific for each group. We analyzed focus group discussions using content analysis and compared themes across groups in a university outpatient internal medicine practice setting. The participants were twenty couples with men age 50 and older who participated in four focus groups. Main outcome measures were participants' views on the content and graphic design of culturally sensitive brochures promoting informed decision making about prostate cancer screening. There were content and graphic design differences in the way ethnic groups wanted information presented about the prostate, prostate cancer, risk, and screening. Caucasians likened the size of the prostate to a walnut; Hispanics, to a small lime. Hispanics emphasized how advanced prostate cancer can be symptomatic; Caucasians, how early prostate cancer can be asymptomatic. African Americans wanted risk information specific for them and the advantages and disadvantages of a PSA and DRE; Hispanics, did not. Caucasians and African Americans sought a more active role for men in informed decision making than Hispanics. Differences in the way African Americans, Hispanics, and Caucasians want information presented about prostate cancer screening suggest there may be cultural differences in the reasonable person standard of informed consent, in attitudes toward the physician–patient relationship, screening, and informed decision making. Physicians promoting informed decision making about controversial screening tests should take cultural sensitivity into account when designing educational interventions and using them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology. 2000;14:267–272,277–280.

    Google Scholar 

  2. Ries LA, Hankey BF, Miller BA, et al: (Eds). Cancer Statistics Review 1973–1988. Bethesda, MD: National Cancer Institute;1991. NIH publication 91–2789.

    Google Scholar 

  3. Coley CM, Barry MJ, Fleming C, et al. Early detection of prostate cancer: I. Prior probability and effectiveness of tests. Ann Intern Med. 1997;126:394–406.

    Google Scholar 

  4. Woolf SH. Screening for prostate cancer with prostate-specific antigen: An examination of the evidence. N Engl J Med. 1995;333:1401–1405.

    Google Scholar 

  5. Barry MJ. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med. 2001;344:1373–1377.

    Google Scholar 

  6. Coley CM, Barry MJ, Fleming C, et al. Early detection of prostate cancer. II. Estimating the risks, benefits, and costs. Ann Intern Med. 1997; 126:468–479.

    Google Scholar 

  7. Krahn MD, Mahoney JE, Eckman MH, et al. Screening for prostate cancer. A decision analytic view. JAMA. 1994; 272:773–780.

    Google Scholar 

  8. Partin AW, Pound CR, Clemens JQ, et al. Serum PSA after anatomic radical prostatectomy: The John Hopkins experience after 10 years. Urol Clin North Am. 1993; 20:713–725.

    Google Scholar 

  9. Walsh PC. Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters. Ann Intern Med. 1993; 119:948–949.

    Google Scholar 

  10. Brawley OW. Prostate cancer screening: a note of caution. In: Thompson IM, Resnick MI, Klein EJ, eds. Screening for Prostate Cancer. Totowa, NJ: Humana Press, Inc, 2001:175–185.

    Google Scholar 

  11. Gohagan JK, Prorok PC, Kramer BS, et al. Prostate cancer screening in the prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. J Urol. 1994; 152: 1905–1909.

    Google Scholar 

  12. Prorok P. The National Cancer Institute Multi-Screening Trial. Can J Oncol. 1994;4(suppl 1): 98–101.

    Google Scholar 

  13. Schroder FH. The European Screening Study for Prostate Cancer. Can J Oncol. 1994; 4(suppl 1): 102–109.

    Google Scholar 

  14. Schroder FH, Kranse R, Rietbergen J, et al. The European randomized study of screening for prostate cancer (ERSPC): an update. Eur Urol. 1999; 35:539–543.

    Google Scholar 

  15. Eschenbach AV, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 1997. CA Cancer J Clin. 1997;47:261–264.

    Google Scholar 

  16. Coley CM, Barry MJ, Mulley AG. Clinical Guideline: Part III. Screening for prostate cancer. Ann Intern Med 1997;126:480–484.

    Google Scholar 

  17. American Academy of Family Physicians. Summary of recommendations for periodic health examination. Available at: http://www.aafp.org/exam/app-d_c.html. Accessed December 3, 1999.

  18. Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Informed consent for PSA screening: Does it happen? Effective Clin Practice 1999; 2:152–157.

    Google Scholar 

  19. O'Dell KJ, Volk RJ, Cass AR, et al. Screening for prostate cancer with the prostate-specific antigen test. Are patients making informed decisions? J Fam Pract. 1999; 48:682–688.

    Google Scholar 

  20. Diefenbach PN, Ganz PA, Pawlow AJ, Guthrie D. Screening by the prostate-specific antigen test: What do the patients know? J Cancer Educ. 1996;11:39–44.

    Google Scholar 

  21. Mainous AG III, Hagen MD. Public awareness of prostate cancer and the prostate-specific antigen test. Cancer Pract 1994; 2:217–221.

    Google Scholar 

  22. Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, Robertson CN. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 1995; 46:346–351.

    Google Scholar 

  23. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000;90:1595–1600.

    Google Scholar 

  24. Hicks RJ, Hamm RM, Bemben DA. Prostate cancer screening: what family physicians believe is best. Arch Fam Med 1995; 4:317–322.

    Google Scholar 

  25. McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC. Screening for prostate cancer: a comparison of urologists and primary care physicians. Southern Med J. 1996; 89:885–888.

    Google Scholar 

  26. Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med. 1995;4:311–315.

    Google Scholar 

  27. Hoffman RM, Blume P, Gilliland F. Prostate-specific antigen testing practices and outcomes. J Gen Intern Med. 1998;13:106–110.

    Google Scholar 

  28. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA Cancer J Clin 1999; 49: 8–31.

    Google Scholar 

  29. Powell IJ. Prostate cancer and African American men. Oncology 1997; 11:599–560.

    Google Scholar 

  30. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF, Pandya PP, Lind ML, Bell NF. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 1993; 72:2569–2573.

    Google Scholar 

  31. Natarajan N, Murphy GP, Mettlin C. Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J Surg Oncol 1989; 40:232–236.

    Google Scholar 

  32. Barber KR, Shaw R, Folts M, Taylor DK, Ryan A, Hughes M, Scott V, Abbott RR. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program. J Community Health 1998; 23:441–451.

    Google Scholar 

  33. Smith GE, DeHaven MJ, Grundig JP, Wilson GR. African-American males and prostate cancer: assessing knowledge levels in the community. J Natl Med Assoc 1997; 89:387–391.

    Google Scholar 

  34. Coronado G, Thompson B. Rural Mexican American men's attitudes and beliefs about cancer screening. J Cancer Educ 2000;15:41–45.

    Google Scholar 

  35. Resnicow K, Baranowski T, Ahluwalia JS, Braithwaite RL. Cultural sensitivity in public health: defined and demystified. Ethn Dis 1999;9:10–21.

    Google Scholar 

  36. Bechtel GA, Davidhizar RE. Integrating cultural diversity in patient education. Semin Nurse Manag 1999;7:193–197.

    Google Scholar 

  37. Brawley OW. Prostate cancer and black men. Semin Urol Oncol 1998;16:184–186.

    Google Scholar 

  38. Gostin LO. Informed consent, cultural sensitivity, and respect for persons. JAMA 1995;274:844–845.

    Google Scholar 

  39. O'Malley AS, Kerner JF, Johnson L. Are we getting the message out to all? Health information sources and ethnicity. Am J Prev Med 1999;17:198–202.

    Google Scholar 

  40. Guidry JJ, Walker VD. Assessing cultural sensitivity in printed cancer materials. Cancer Pract 1999; 7:291–296.

    Google Scholar 

  41. Guidry JJ, Fagan P, Walker V. Cultural sensitivity and readability of breast and prostate printed cancer education materials targeting African Americans. J Natl Med Assoc 1998;90:165–169.

    Google Scholar 

  42. Mohrmann CC, Coleman EA, Coon SK, Lord JE, Heard JK, Cantrell MJ, Burks EC. An analysis of printed breast cancer information for African American women. J Cancer Educ 2000;15:23–27.

    Google Scholar 

  43. Massett HA. Appropriateness of Hispanic print materials: a content analysis. Health Educ Res 1996;11:231–242.

    Google Scholar 

  44. Price JH, Everett SA. Developing cancer pamphlets for economically disadvantaged African Americans. Patient Educ Couns 1996;28:159–167.

    Google Scholar 

  45. Chan ECY, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent? Am J Med. 1998; 105:266–274.

    Google Scholar 

  46. Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. Middleton, Wisconsin: Green Briar Press; 1986.

    Google Scholar 

  47. Health Promotion for Men 50+. Washington, DC: American Association of Retired Persons;1994.

  48. Rubenstein L. Strategies to overcome barriers to early detection of cancer among older adults. Cancer 1994;74:2190–2193.

    Google Scholar 

  49. Stair J. Public awareness of screening programs. Oncol Nurs Forum. 1992;19:93–94.

    Google Scholar 

  50. Krueger RA, ed. Focus Groups A Practical Guide for Applied Research. 2nd ed. Thousand Oaks, CA: Sage Publications, Inc., 1994.

  51. Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM, Members of the Prostate Patient Outcomes Research Team. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med 1996; 11:342–349.

    Google Scholar 

  52. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med 1999; 8:333–340.

    Google Scholar 

  53. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 4th ed. New York: Oxford University Press; 1994:120–188.

    Google Scholar 

  54. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York: Oxford University Press; 1986.

    Google Scholar 

  55. Sprung DL, Winick BJ. Informed consent in theory and practice: legal and medical perspectives on the informed consent doctrine and a proposed reconceptualization. Crit Care Med 1989;17: 1346–1354.

    Google Scholar 

  56. Russell LD, Alexander MK, Corbo KF. Developing culture-specific interventions for Latinas to reduce high-risk behaviors. J Assoc Nurses AIDS Care 2000;11:70–76.

    Google Scholar 

  57. Perez-Stable EJ, Sabogal F, Otero-Sabogal R, Hiatt RA, McPhee SJ. Misconceptions about cancer among Latinos and Anglos. JAMA 1992;268:3219–3223.

    Google Scholar 

  58. Larkey LK, Hecht ML, Miller K, Alatorre C. Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav 2001;28:65–80.

    Google Scholar 

  59. Zimmerman SM. Factors influencing Hispanic participation in prostate cancer screening. Oncol Nurs Forum 1997;24:499–504.

    Google Scholar 

  60. Ramirez AG, McAlister A, Gallion KJ, Villarreal R. Targeting Hispanic populations: future research and prevention strategies. Environ Health Perspect 1995;103(Suppl 8):287–290.

    Google Scholar 

  61. Council of Scientific Affairs. Hispanic Health in the United States. JAMA 1991;265:248–252.

    Google Scholar 

  62. Robinson SB, Ashley M, Haynes MA. Attitudes of African Americans regarding screening for prostate cancer. J Natl Med Assoc 1996;88:241–246.

    Google Scholar 

  63. McCoy CB, Anwyl RS, Metsch LR, Inciardi JA, Smith SA, Correa R. Prostate cancer in Florida knowledge, attitudes, practices, and beliefs. Cancer Pract 1995;3:88–93.

    Google Scholar 

  64. Myers RE, Wolf TA, McKee L, et.al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78:471–479.

    Google Scholar 

  65. Olsen SJ, Frank-Stromberg M. Cancer prevention and early detection in ethnically diverse populations. Semin Oncol Nurs 1993;9:198–209.

    Google Scholar 

  66. A Study of Hispanics' Attitudes Concerning Cancer and Cancer Prevention. Atlanta, Ga: American Cancer Society; 1985.

  67. Powe BD. Cancer fatalism among African-Americans: a review of the literature. Nurs Outlook 1996; 44:18–21.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, The University of Texas-Houston Medical School, 6431 Fannin, 1.122 MSB, Houston, TX, 77030

    Evelyn C. Y. Chan

  2. Center for Health Promotion and Prevention Research, The University of Texas-Houston School of Public Health, Houston, TX

    Michelle C. Haynes, Frederick T. O'Donnell, Carolyn Bachino & Sally W. Vernon

Authors
  1. Evelyn C. Y. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle C. Haynes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frederick T. O'Donnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carolyn Bachino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sally W. Vernon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, E.C.Y., Haynes, M.C., O'Donnell, F.T. et al. Cultural Sensitivity and Informed Decision Making About Prostate Cancer Screening. Journal of Community Health 28, 393–405 (2003). https://doi.org/10.1023/A:1026072022853

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026072022853

Search

Navigation